93 related articles for article (PubMed ID: 2010619)
1. A novel enzyme-linked immunosorbent assay (ELISA) for the detection of beryllium antibodies.
Clarke SM
J Immunol Methods; 1991 Mar; 137(1):65-72. PubMed ID: 2010619
[TBL] [Abstract][Full Text] [Related]
2. Application of beryllium antibodies in risk assessment and health surveillance: two case studies.
Clarke SM; Thurlow SM; Hilmas DE
Toxicol Ind Health; 1995; 11(4):399-411. PubMed ID: 8748421
[TBL] [Abstract][Full Text] [Related]
3. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
Maier LA; Kittle LA; Mroz MM; Newman LS
Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
[TBL] [Abstract][Full Text] [Related]
4. [Beryllium--underestimated occupational health hazard in Poland].
Dudek W; Walusiak J; Wittczak T
Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in-house biotin-avidin tetanus IgG enzyme-linked-immunosorbent assay (ELISA) with gold standard in vivo mouse neutralization test for the detection of low level antibodies.
Sonmez C; Coplu N; Gozalan A; Akin L; Esen B
J Immunol Methods; 2017 Jun; 445():67-70. PubMed ID: 28322862
[TBL] [Abstract][Full Text] [Related]
6. Comparison of lymphocyte transformation and macrophage migration inhibition tests in the detection of beryllium hypersensitivity.
Williams WR; Williams WJ
J Clin Pathol; 1982 Jun; 35(6):684-7. PubMed ID: 7085919
[TBL] [Abstract][Full Text] [Related]
7. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
Kreiss K; Wasserman S; Mroz MM; Newman LS
J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
[TBL] [Abstract][Full Text] [Related]
8. Beryllium BioBank: 2. Lymphocyte proliferation testing.
Harber P; Su J; Alongi G
J Occup Environ Med; 2014 Aug; 56(8):857-60. PubMed ID: 25099413
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of chronic berylliosis].
Schreiber J; Zissel G; Greinert U; Galle J; Schulz KH; Schlaak M; Müller-Quernheim J
Pneumologie; 1999 Apr; 53(4):193-8. PubMed ID: 10409861
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
[TBL] [Abstract][Full Text] [Related]
11. CpG promoter methylation status is not a prognostic indicator of gene expression in beryllium challenge.
Tooker BC; Ozawa K; Newman LS
J Immunotoxicol; 2016 May; 13(3):417-27. PubMed ID: 26673671
[TBL] [Abstract][Full Text] [Related]
12. Beryllium disease among construction trade workers at Department of Energy nuclear sites.
Welch LS; Ringen K; Dement J; Bingham E; Quinn P; Shorter J; Fisher M
Am J Ind Med; 2013 Oct; 56(10):1125-36. PubMed ID: 23794247
[TBL] [Abstract][Full Text] [Related]
13. Role of in vitro and in vivo tests of hypersensitivity in beryllium workers.
Price CD; Williams WJ; Pugh A; Joynson DH
J Clin Pathol; 1977 Jan; 30(1):24-28. PubMed ID: 320228
[TBL] [Abstract][Full Text] [Related]
14. Value of beryllium lymphocyte transformation tests in chronic beryllium disease and in potentially exposed workers.
Williams WJ; Williams WR
Thorax; 1983 Jan; 38(1):41-4. PubMed ID: 6845261
[TBL] [Abstract][Full Text] [Related]
15. [Chronic Beryllium disease after exposure to low-beryllium-content copper].
Hasejima N; Kobayashi H; Takezawa S; Yamato K; Kadoyama C; Kawano Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1105-10. PubMed ID: 8544383
[TBL] [Abstract][Full Text] [Related]
16. Rocky Flats Beryllium Health Surveillance.
Stange AW; Furman FJ; Hilmas DE
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):981-6. PubMed ID: 8933045
[TBL] [Abstract][Full Text] [Related]
17. Beryllium exposure: dermal and immunological considerations.
Day GA; Stefaniak AB; Weston A; Tinkle SS
Int Arch Occup Environ Health; 2006 Feb; 79(2):161-4. PubMed ID: 16231190
[TBL] [Abstract][Full Text] [Related]
18. A study on the beryllium lymphocyte transformation test and the beryllium levels in working environment.
Yoshida T; Shima S; Nagaoka K; Taniwaki H; Wada A; Kurita H; Morita K
Ind Health; 1997 Jul; 35(3):374-9. PubMed ID: 9248221
[TBL] [Abstract][Full Text] [Related]
19. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
[TBL] [Abstract][Full Text] [Related]
20. [Establishment and diagnostic performance of biotin-avidin complex enzyme linked immunosorbent assay of detecting specific IgG4 of clonorchiasis].
Wang J; Song LJ; Yu CX; Shen S; Xu YL; Yin XR; Ke XD; Gao H; Liu Q
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Apr; 27(2):156-61. PubMed ID: 26263776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
